Who Owns Lisata Therapeutics Stock?
NASDAQ: LSTAHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Ownership breakdown
- Held by institutions
- 13.41%
- Held by insiders
- 22.26%
- Institutional holders
- 33
- Institutions 13.4%
- Insiders 22.3%
- Public and other 64.3%
Who owns Lisata Therapeutics stock?
Institutional investors own about 13.4% of Lisata Therapeutics's shares, spread across 33 institutions that file 13F reports. That level of institutional ownership is relatively low, leaving more of the stock with retail investors and insiders. Insiders, including executives, directors and large founding shareholders, hold 22.26% of LSTA.
The largest institutional holders are Deeter Investments Llp (4.04%), Vanguard Capital Management LLC (3.09%) and Yakira Capital Management, Inc. (1.54%). Together, the top 10 institutions control 14.3% of shares outstanding. In their latest filings, 8 of the top 10 institutions increased their LSTA positions and 1 reduced them.
Summary generated from market data by MetaCap's automated system. Methodology
Top institutional holders of LSTA
| Institution | Shares | % Held | Change |
|---|---|---|---|
| Deeter Investments Llp | 364.48K | 4.04% | +100.0% |
| Vanguard Capital Management LLC | 278.84K | 3.09% | +2.6% |
| Yakira Capital Management, Inc. | 138.56K | 1.54% | +100.0% |
| CSS LLC | 110.42K | 1.23% | +78.4% |
| Deltec Asset Management LLC | 83.20K | 0.92% | -7.6% |
| Rangeley Capital, LLC | 81.00K | 0.90% | +8.0% |
| Geode Capital Management, LLC | 72.63K | 0.81% | +2.5% |
| Virtu Financial LLC | 58.78K | 0.65% | +39.3% |
| Blackrock Inc. | 54.86K | 0.61% | 0.0% |
| Vanguard Fiduciary Trust Co | 48.96K | 0.54% | +40.2% |
% held is the share of total shares outstanding. Change is the percentage change in the position since the holder's previous 13F filing.
Top mutual fund and ETF holders of LSTA
| Fund | Shares | % Held |
|---|---|---|
| VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund | 191.37K | 2.12% |
| VANGUARD INDEX FUNDS-Vanguard Extended Market Index Fund | 80.44K | 0.89% |
| Fidelity Concord Street Trust-Fidelity Extended Market Index Fund | 38.27K | 0.42% |
| Fidelity Concord Street Trust-Fidelity Series Total Market Index Fund | 10.37K | 0.12% |
| VANGUARD VALLEY FORGE FUNDS-Vanguard Balanced Index Fund | 7.02K | 0.08% |
| Fidelity Concord Street Trust-Fidelity Nasdaq Composite Index Fund | 4.43K | 0.05% |
| Fidelity Concord Street Trust-Fidelity Total Market Index Fund | 4.38K | 0.05% |
| DFA INVESTMENT DIMENSIONS GROUP INC-U.S. Social Core Eqy. 2 PORT. | 2.19K | 0.02% |
| Dimensional ETF Trust-Dimensional US Sustainability Core 1 ETF | 100 | 0.00% |
| Dimensional ETF Trust-Dimensional US Core Equity 1 ETF | 8 | 0.00% |
Frequently asked questions
Who is the largest shareholder of Lisata Therapeutics?
Deeter Investments Llp is the largest institutional shareholder of LSTA, owning 4.04% of shares outstanding (364.48K shares) as of its latest 13F filing.
What percentage of Lisata Therapeutics is owned by institutions?
Institutions own about 13.4% of LSTA shares and 17.3% of the public float.
How much of Lisata Therapeutics do insiders own?
Insiders, such as officers and directors, own about 22.26% of LSTA shares outstanding.
Where does institutional ownership data come from?
Investment managers with more than $100 million in US equities must file Form 13F with the SEC within 45 days of each quarter-end. Holdings are therefore up to about 4.5 months old when published.